Stock Market News
People at high risk to mpox should get 2 doses of Bavarian Nordic vaccine, US CDC says
2023.05.18 13:20
© Reuters. FILE PHOTO: An employee of the vaccine company Bavarian Nordic works in a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. The company, headquartered in Denmark, is the only one in the world to have approval for a smallpox vacc
(Reuters) – The U.S. Centers for Disease Control and Prevention is urging people at high risk of mpox to get two doses of Bavarian Nordic’s Jynneos vaccine, based on new evidence from a U.S. study showing that two doses were more effective at preventing infection than one, officials said on Thursday.
The study, published on Thursday, offered some of the first evidence on the efficacy of the Jynneos vaccine, which was deployed last year during a global outbreak of mpox that affected more than 30,000 people in the United States.